Skip to main content
Journal cover image

ADOPTIVE LYMPHOCYTE THERAPY (ALT) PLUS DENDRITIC CELL VACCINATION (DCV) AFTER MYELOABLATIVE (MA) OR NON-MYELOABLATIVE (NMA) CONDITIONING IN PATIENTS WITH RECURRENT CENTRAL PNET (C-PNET)

Publication ,  Journal Article
Gururangan, S; Grant, GA; Driscoll, T; Archer, G; Sayour, EJ; Herndon, JE; Friedman, HS; Kurtzberg, J; Bigner, DD; Sampson, JH; Mitchell, DA
Published in: PEDIATRIC BLOOD & CANCER
September 1, 2013

Duke Scholars

Published In

PEDIATRIC BLOOD & CANCER

EISSN

1545-5017

ISSN

1545-5009

Publication Date

September 1, 2013

Volume

60

Start / End Page

13 / 13

Publisher

WILEY-BLACKWELL

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3213 Paediatrics
  • 3211 Oncology and carcinogenesis
  • 1114 Paediatrics and Reproductive Medicine
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Gururangan, S., Grant, G. A., Driscoll, T., Archer, G., Sayour, E. J., Herndon, J. E., … Mitchell, D. A. (2013). ADOPTIVE LYMPHOCYTE THERAPY (ALT) PLUS DENDRITIC CELL VACCINATION (DCV) AFTER MYELOABLATIVE (MA) OR NON-MYELOABLATIVE (NMA) CONDITIONING IN PATIENTS WITH RECURRENT CENTRAL PNET (C-PNET). PEDIATRIC BLOOD & CANCER, 60, 13–13.
Gururangan, S., G. A. Grant, T. Driscoll, G. Archer, E. J. Sayour, J. E. Herndon, H. S. Friedman, et al. “ADOPTIVE LYMPHOCYTE THERAPY (ALT) PLUS DENDRITIC CELL VACCINATION (DCV) AFTER MYELOABLATIVE (MA) OR NON-MYELOABLATIVE (NMA) CONDITIONING IN PATIENTS WITH RECURRENT CENTRAL PNET (C-PNET).” PEDIATRIC BLOOD & CANCER 60 (September 1, 2013): 13–13.
Gururangan S, Grant GA, Driscoll T, Archer G, Sayour EJ, Herndon JE, et al. ADOPTIVE LYMPHOCYTE THERAPY (ALT) PLUS DENDRITIC CELL VACCINATION (DCV) AFTER MYELOABLATIVE (MA) OR NON-MYELOABLATIVE (NMA) CONDITIONING IN PATIENTS WITH RECURRENT CENTRAL PNET (C-PNET). PEDIATRIC BLOOD & CANCER. 2013 Sep 1;60:13–13.
Gururangan S, Grant GA, Driscoll T, Archer G, Sayour EJ, Herndon JE, Friedman HS, Kurtzberg J, Bigner DD, Sampson JH, Mitchell DA. ADOPTIVE LYMPHOCYTE THERAPY (ALT) PLUS DENDRITIC CELL VACCINATION (DCV) AFTER MYELOABLATIVE (MA) OR NON-MYELOABLATIVE (NMA) CONDITIONING IN PATIENTS WITH RECURRENT CENTRAL PNET (C-PNET). PEDIATRIC BLOOD & CANCER. WILEY-BLACKWELL; 2013 Sep 1;60:13–13.
Journal cover image

Published In

PEDIATRIC BLOOD & CANCER

EISSN

1545-5017

ISSN

1545-5009

Publication Date

September 1, 2013

Volume

60

Start / End Page

13 / 13

Publisher

WILEY-BLACKWELL

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3213 Paediatrics
  • 3211 Oncology and carcinogenesis
  • 1114 Paediatrics and Reproductive Medicine
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences